Gruss micrea
|
Melinta plant einen 110 Mio. $ Kapitalerhöhung
"Melinta Therapeutics, Inc., a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced the pricing of an underwritten public offering of 22,000,000 shares of its common stock at $5.00 per share, before underwriting discounts and commissions. The size of the offering was upsized from $75,000,000 to $110,000,000. In addition, the underwriters have a 30-day option to purchase up to an additional 2,640,000 shares of common stock from Melinta on the same terms and conditions."
ir.melinta.com/news-releases/...pricing-public-offering-common
56 Mio. $ Verlust in Q2/18
ir.melinta.com/news-releases/...-second-quarter-2018-financial
Earnings Call Transcript
seekingalpha.com/article/...-results-earnings-call-transcript
neuer Interim CEO Johnson
ir.melinta.com/news-releases/...ces-appointment-john-h-johnson
Positive Top-Line Results in Phase III Trial of Baxdela® (delafloxacin) for Treatment of CABP
ir.melinta.com/news-releases/...ositive-top-line-results-phase
seekingalpha.com/news/...premarket-positive-delafloxacin-data
Stellenstreichungen bei Melinta
endpts.com/...ff-as-it-struggles-to-grow-antibiotics-revenue/
|
Wertung | Antworten | Thema | Verfasser | letzter Verfasser | letzter Beitrag | |
2 | 1 | Melinta Therapeutics (MLNT) | Chalifmann3 | Balu4u | 25.04.21 02:34 | |
83 | Cempra - big potential | micrea | Vassago | 13.01.20 16:57 |